WORK Medical Technology Group LTD has announced an exclusive distribution agreement with Shanghai Benke Medical Technology Co., Ltd. to distribute its AI-Automated Blood Cell Morphology Analyzer in East China throughout 2026. The agreement includes a minimum annual sales target of RMB 10 million. The Analyzer is a Class II medical device certified under applicable national and industry standards, offering high imaging speed and classification accuracy. The collaboration aims to accelerate market access and drive large-scale commercialization of the new product. This move is expected to strengthen WORK Medical’s brand presence and pave the way for international expansion.

Read more at GlobeNewswire: WORK Medical Grants East China Exclusive Distribution